Previous close | 105.92 |
Open | 106.23 |
Bid | 106.32 x 800 |
Ask | 106.52 x 800 |
Day's range | 105.52 - 106.53 |
52-week range | 82.73 - 115.49 |
Volume | |
Avg. volume | 8,818,146 |
Market cap | 270.081B |
Beta (5Y monthly) | 0.35 |
PE ratio (TTM) | 18.63 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 2.92 (2.74%) |
Ex-dividend date | 14 Mar 2023 |
1y target est | N/A |
The Indian government said on Thursday it was providing a full exemption from basic customs duty for rare disease therapies and Merck & Co Inc's cancer therapy Keytruda when such medicines were imported for personal use. The government said in a statement that while some drugs such as treatments for spinal muscular atrophy or Duchenne muscular dystrophy are already exempted from customs duty, it had received many requests for relief from import tax for other rare disease drugs.
Yahoo Finance Live’s Brad Smith breaks down how stocks are trading following the opening bell on Wednesday.
In the latest trading session, Merck (MRK) closed at $105.53, marking a -1.31% move from the previous day.